These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14649216)

  • 41. Clinical potential of aldose reductase inhibitors in diabetic neuropathy.
    Hamada Y; Nakamura J
    Treat Endocrinol; 2004; 3(4):245-55. PubMed ID: 16026107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy.
    Cohen KL; Harris S
    Arch Intern Med; 1987 Aug; 147(8):1442-4. PubMed ID: 3115210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Significance of aldose-reductase inhibition with traditional Chinese and Western drugs in the treatment of diabetic peripheral neuropathy].
    Liang X; Guo S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Jul; 19(7):442-4. PubMed ID: 11783220
    [No Abstract]   [Full Text] [Related]  

  • 44. Results of 20 years of research on the treatment of diabetic retinopathy.
    Ferris FL
    Prev Med; 1994 Sep; 23(5):740-2. PubMed ID: 7845951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence.
    Masson EA; Boulton AJ
    Drugs; 1990 Feb; 39(2):190-202. PubMed ID: 2109678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BMS-275291. Bristol-Myers Squibb.
    Poulaki V
    Curr Opin Investig Drugs; 2002 Mar; 3(3):500-4. PubMed ID: 12054103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme.
    Green AJ; Jaspan JB
    J Diabet Complications; 1990; 4(4):138-44. PubMed ID: 2151223
    [No Abstract]   [Full Text] [Related]  

  • 48. Prasugrel, a third generation thienopyridine and potent platelet inhibitor.
    Gurbel PA; Tantry US
    Curr Opin Investig Drugs; 2008 Mar; 9(3):324-36. PubMed ID: 18311669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inhibitory effect of 7 agents on bovine testis aldose reductase].
    Liu C; Zhu X
    Zhongguo Zhong Yao Za Zhi; 1997 Jun; 22(6):372-3, inside back cover. PubMed ID: 11038893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of diabetic neuropathy].
    Frati-Munari AC; Ariza-Andraca CR
    Gac Med Mex; 1998; 134(1):85-92. PubMed ID: 9658700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia.
    Burnett JR
    Curr Opin Investig Drugs; 2006 Sep; 7(9):850-6. PubMed ID: 17002264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.
    Young RJ; Ewing DJ; Clarke BF
    Diabetes; 1983 Oct; 32(10):938-42. PubMed ID: 6225686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [SG-210].
    Akira T; Naka H
    Nihon Rinsho; 1997 Nov; 55 Suppl():216-20. PubMed ID: 9434470
    [No Abstract]   [Full Text] [Related]  

  • 54. Fidarestat. Aldos, SK 860, SNK 860.
    Drugs R D; 2002; 3(4):232-4. PubMed ID: 12455198
    [No Abstract]   [Full Text] [Related]  

  • 55. Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumors.
    Choueiri TK
    Curr Opin Investig Drugs; 2008 Jun; 9(6):658-71. PubMed ID: 18516765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New approaches for treatment in diabetes: aldose reductase inhibitors.
    Hotta N
    Biomed Pharmacother; 1995; 49(5):232-43. PubMed ID: 7579002
    [No Abstract]   [Full Text] [Related]  

  • 57. Ilepatril (AVE-7688), a vasopeptidase inhibitor for the treatment of hypertension.
    Tabrizchi R
    Curr Opin Investig Drugs; 2008 Mar; 9(3):301-9. PubMed ID: 18311667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15 K crystal structure of the ternary complex refined at 0.78 A resolution: implications for the inhibition mechanism.
    Zhao HT; Hazemann I; Mitschler A; Carbone V; Joachimiak A; Ginell S; Podjarny A; El-Kabbani O
    J Med Chem; 2008 Mar; 51(5):1478-81. PubMed ID: 18284183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Edotecarin.
    Denny WA
    IDrugs; 2004 Feb; 7(2):173-7. PubMed ID: 15057663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aldose reductase inhibitor].
    Hotta N
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():147-54. PubMed ID: 21667476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.